Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-01-18
2005-01-18
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000
Reexamination Certificate
active
06844323
ABSTRACT:
The present invention discloses a new polypeptide-calcitonin 11, the polynucleotide encoding it and a method producing the polypeptide by recombinant DNA technology. The present invention further discloses a method using the polypeptide to treat various disorders, e.g. malignant neoplasm, hematopathy, HIV infection and immunological disease and various inflammation etc. The present invention also discloses agonists of the polypeptide and their therapeutic uses. The present invention further discloses the use of the polynucleotide encoding the new calcitonin 11.
REFERENCES:
DNA Res. 6(1), 63-70 (1999), Nagase T., et al.,Prediction of the sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
Genome Res. 9(3), 242-250 (1999), Reboul, J., Et al.,Comparative genomic analysis of the interferon/Interleukin-10 receptor gene cluster.
Mao Yumin
Xie Yi
BioWindow Gene Development Inc.
Crowell & Moring LLP
Wax Robert A.
LandOfFree
Polypeptide-calcitonin 11 and the polynucleotide encoding it does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptide-calcitonin 11 and the polynucleotide encoding it, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide-calcitonin 11 and the polynucleotide encoding it will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3389101